The Korean pharmaceutical exported some 440,000 doses of its SKYCellflu vaccine to its Thai partner, Biogenetech.
The flu season is back in full swing, and so is SK bioscience’s production of Korea’s first and only cell-based influenza vaccine.
Korea JoongAng Daily Sitemap